Health In Tech, Inc. recently held its 2026 Annual Meeting of Stockholders on November 10, 2026, where significant proposals were approved that could shape the company's future. The meeting saw a strong turnout, with approximately 90.53% of the voting power represented. This event is crucial as it indicates the company’s strategic direction and governance, particularly in the competitive insurance sector.

Background

Health In Tech, Inc. operates under the SIC classification of 6411, which pertains to Insurance Agents, Brokers & Services. The company trades on the Nasdaq under the ticker symbol HIT. As a smaller reporting company and an emerging growth entity, Health In Tech is focused on expanding its market presence and enhancing shareholder value.

What the Filing Says

The SEC filing reveals that during the Annual Meeting, stockholders approved several key proposals. Notably, an amendment to increase the total authorized shares of capital stock from 220 million to 720 million was ratified. This includes 650 million shares of Class A Common Stock, 50 million shares of Class B Common Stock, and 20 million shares of Series A Preferred Stock. Furthermore, stockholders elected five directors, including new nominee Tim Cortes, and ratified the appointment of MaloneBailey, LLP as the company’s independent auditors.

Impact

The decisions made during the Annual Meeting are expected to significantly impact the company’s governance and operational capabilities. By increasing the number of authorized shares, Health In Tech may have greater flexibility in raising capital and incentivizing employees through equity compensation. This move could also affect stockholder sentiment and attract potential investors, positioning the company favorably against its competitors in the insurance industry.

What's Next

Following the Annual Meeting, Health In Tech, Inc. will likely continue to implement the approved changes and monitor their effects on the company’s performance and stockholder relations. The filing does not specify any immediate subsequent actions, but stakeholders will be keenly observing how these decisions unfold in the coming months.